Cargando…

Renal oxalate stones in children with Zellweger spectrum disorders

Peroxisomal biogenesis disorders due to PEX gene defects are classified into many subgroups, of which Zellweger spectrum disorders (ZSDs) represent the major subgroup. The ZSDs are clinical and biochemical disorders divided into three phenotypes: neonatal, adolescence, or adult. Clinical presentatio...

Descripción completa

Detalles Bibliográficos
Autor principal:	Alhazmi, Hamdan Hammad
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2018
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5875229/ https://www.ncbi.nlm.nih.gov/pubmed/29628851 http://dx.doi.org/10.4103/sja.SJA_699_17

Ejemplares similares

An Infant with Blended Phenotype of Zellweger Spectrum Disorder and Congenital Muscular Dystrophy
por: Gupta, Priyanka, et al.
Publicado: (2021)

Acute Late-Onset Cirrhosis in Zellweger Spectrum Disorder
por: Hsu, Mark, et al.
Publicado: (2023)

Long-Term Cholic Acid Therapy in Zellweger Spectrum Disorders
por: Heubi, James E., et al.
Publicado: (2018)

Cholic acid therapy in Zellweger spectrum disorders
por: Berendse, Kevin, et al.
Publicado: (2016)

Zellweger spectrum disorders: clinical overview and management approach
por: Klouwer, Femke C. C., et al.
Publicado: (2015)

Cholbam® and Zellweger spectrum disorders: treatment implementation and management
por: Anderson, Janaina Nogueira, et al.
Publicado: (2021)

Long-Term Cholic Acid Treatment in a Patient with Zellweger Spectrum Disorder
por: Heubi, James E., et al.
Publicado: (2018)

Emotional experience in parents of children with Zellweger spectrum disorders: A qualitative study
por: Bose, Mousumi, et al.
Publicado: (2019)

A Drosophila model for the Zellweger spectrum of peroxisome biogenesis disorders
por: Mast, Fred D., et al.
Publicado: (2011)

High prevalence of primary adrenal insufficiency in Zellweger spectrum disorders
por: Berendse, Kevin, et al.
Publicado: (2014)

Zellweger spectrum disorders: clinical manifestations in patients surviving into adulthood
por: Berendse, Kevin, et al.
Publicado: (2015)

Coagulopathy in Zellweger spectrum disorders: a role for vitamin K
por: Zeynelabidin, Sara, et al.
Publicado: (2017)

A novel PEX1 mutation in a Moroccan family with Zellweger spectrum disorders
por: Bousfiha, Amale, et al.
Publicado: (2017)

Identification of a novel mutation in PEX10 in a patient with attenuated Zellweger spectrum disorder: a case report
por: Blomqvist, Maria, et al.
Publicado: (2017)

Mild form of Zellweger Spectrum Disorders (ZSD) due to variants in PEX1: Detailed clinical investigation in a 9-years-old female
por: Barillari, Maria Rosaria, et al.
Publicado: (2020)

Reply: Low bone mineral density is a common feature of Zellweger spectrum disorders
por: Klouwer, Femke C.C., et al.
Publicado: (2016)

Reply: Low bone mineral density is a common feature of Zellweger spectrum disorders
por: Rush, Eric T., et al.
Publicado: (2016)

Genotype–phenotype correlations and disease mechanisms in PEX13-related Zellweger spectrum disorders
por: Borgia, Paola, et al.
Publicado: (2022)

Genome sequencing identifies a rare case of moderate Zellweger spectrum disorder caused by a PEX3 defect: Case report and literature review
por: Lee, Whiwon, et al.
Publicado: (2020)

Aggregation of Calcium Phosphate and Oxalate Phases in the Formation of Renal Stones
por: Xie, Baoquan, et al.
Publicado: (2014)

Prenatal diagnosis of zellweger syndrome by fetal MRI: a case report
por: Diaz, Joana, et al.
Publicado: (2021)

Uncombable Hair in a Case of Zellweger Syndrome – A New Association
por: Jahnavi, Yatham, et al.
Publicado: (2023)

Carrier frequency estimation of Zellweger spectrum disorder using ExAC database and bioinformatics tools
por: Vasiljevic, Eva, et al.
Publicado: (2019)

Oral Cholic Acid Is Efficacious and Well Tolerated in Patients With Bile Acid Synthesis and Zellweger Spectrum Disorders
por: Heubi, James E., et al.
Publicado: (2017)

Neonate with classic Zellweger syndrome
por: Kashgari, Amna
Publicado: (2019)

Daily Green Tea Infusions in Hypercalciuric Renal Stone Patients: No Evidence for Increased Stone Risk Factors or Oxalate-Dependent Stones
por: Rode, Julie, et al.
Publicado: (2019)

A newly identified mutation in the PEX26 gene is associated with a milder form of Zellweger spectrum disorder
por: Tanaka, Akemi J., et al.
Publicado: (2019)

Hyperinsulinism in a patient with a Zellweger Spectrum Disorder and a 16p11.2 deletion syndrome
por: Hoytema van Konijnenburg, Eva M.M., et al.
Publicado: (2020)

Zellweger spectrum disorder: A cross-sectional study of symptom prevalence using input from family caregivers
por: Bose, Mousumi, et al.
Publicado: (2020)

Recombinant Lactobacillus plantarum expressing and secreting heterologous oxalate decarboxylase prevents renal calcium oxalate stone deposition in experimental rats
por: Sasikumar, Ponnusamy, et al.
Publicado: (2014)

A clinical case of Zellweger syndrome in a patient with a previous history of ocular medulloepithelioma
por: Galvez-Ruiz, Alberto, et al.
Publicado: (2018)

Formation of a calcium oxalate urethral stone in a 3‐year‐old boy due to hypocitraturia
por: Kita, Nobuhisa, et al.
Publicado: (2020)

Diet in Different Calcium Oxalate Kidney Stones
por: Coello, Iris, et al.
Publicado: (2023)

Mild Zellweger syndrome due to functionally confirmed novel PEX1 variants
por: Lipiński, Patryk, et al.
Publicado: (2019)

A novel mutation in the PEX26 gene in a family from Dagestan with members affected by Zellweger spectrum disorder
por: Semenova, Natalia A., et al.
Publicado: (2021)

Characterization of Severity in Zellweger Spectrum Disorder by Clinical Findings: A Scoping Review, Meta-Analysis and Medical Chart Review
por: Bose, Mousumi, et al.
Publicado: (2022)

Abnormal activation of MAPKs pathways and inhibition of autophagy in a group of patients with Zellweger spectrum disorders and X-linked adrenoleukodystrophy
por: Gragnaniello, Vincenza, et al.
Publicado: (2023)

Redo laparoscopic pyeloplasty among children: A systematic review and meta-analysis
por: Alhazmi, Hamdan Hammad
Publicado: (2018)

Ferrostatin-1 alleviates oxalate-induced renal tubular epithelial cell injury, fibrosis and calcium oxalate stone formation by inhibiting ferroptosis
por: Xie, Jinna, et al.
Publicado: (2022)

Primary Nonfunction of Renal Allograft Secondary to Acute Oxalate Nephropathy
por: Parasuraman, Ravi, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_2jrjkofav6d4t0mmlnu659jple